Renal cell carcinoma (RCC) is the most common type of kidney cancer and one of the most challenging to treat in advanced stages.
While localised tumors can often be treated with surgery, m
Following cancer treatment, lymph node macrophages induced IL-33, a cytokine known for its roles in immune homeostasis and inflammation.1,2
In tumor setting, however, IL-33 fuels immune su
In the rapidly evolving field of molecular diagnostics and precision medicine, exosomes and their cargo have emerged as critical disease biomarkers. These tiny extracellular vesicles, found in bodil
Pancreatic cancer (PC) is one of the most aggressive and challenging cancers to treat, accounting for a significant proportion of cancer-related deaths worldwide (Yang et al., 2024). With a five-yea
Colorectal cancer (CRC), also known as bowel cancer, is one of the most common cancers worldwide. Affecting the colon or rectum, it often begins as noncancerous growths called polyps, which can
Over the past few years, there has been a lot of talk and numerous studies published surrounding the relationship between the gut microbiota and overall human health. Recently, studies have shown an a
Cancer is the second leading cause of death in both men and women worldwide. In 2020, 1.41 million people were diagnosed with prostate cancer worldwide.1 With over 300,000 deaths caused by prostate ca
Cancer is a term for a group of heterogeneous diseases in which cells grow uncontrollably and can eventually spread throughout the body. Traditional first-line treatment of cancer includes localized t
Colorectal Cancer (CRC), or bowel cancer, which includes colon cancer and rectal cancer, is a disease in which the cells of the colon, or rectum, grow and divide uncontrollably.
The colon
This month, we’re focusing on four recent articles that made use of Norgen’s technology to explore different aspects of nutrition. The first two papers investigate the effect of nutritional intervent